Compliance of clinical trial registries with the World Health Organization minimum data set : a survey

dc.contributor.authorMoja, Lorenzo P.
dc.contributor.authorMoschetti, Ivan
dc.contributor.authorNurbhai, Munira
dc.contributor.authorCompagnoni, Anna
dc.contributor.authorLiberati, Alessandro
dc.contributor.authorGrimshaw, Jeremy M.
dc.contributor.authorChan, An-Wen
dc.contributor.authorDickersin, Kay
dc.contributor.authorKrleza-Jeric, Karmela
dc.contributor.authorMoher, David
dc.contributor.authorSim, Ida
dc.contributor.authorVolmink, Jimmy
dc.date.accessioned2011-11-04T12:34:43Z
dc.date.available2011-11-04T12:34:43Z
dc.date.issued2009-07
dc.date.updated2011-11-03T06:14:40Z
dc.descriptionThe original publication is available at http://www.trialsjournal.com/content/10/1/56
dc.description.abstractBackground: Since September 2005 the International Committee of Medical Journal Editors has required that trials be registered in accordance with the World Health Organization (WHO) minimum dataset, in order to be considered for publication. The objective is to evaluate registries' and individual trial records' compliance with the 2006 version of the WHO minimum data set. Methods: A retrospective evaluation of 21 online clinical trial registries (international, national, specialty, pharmaceutical industry and local) from April 2005 to February 2007 and a cross-sectional evaluation of a stratified random sample of 610 trial records from the 21 registries. Results: Among 11 registries that provided guidelines for registration, the median compliance with the WHO criteria were 14 out of 20 items (range 6 to 20). In the period April 2005–February 2007, six registries increased their compliance by six data items, on average. None of the local registry websites published guidelines on the trial data items required for registration. Slightly more than half (330/610; 54.1%, 95% CI 50.1% – 58.1%) of trial records completed the contact details criteria while 29.7% (181/610, 95% CI 26.1% – 33.5%) completed the key clinical and methodological data fields. Conclusion: While the launch of the WHO minimum data set seemed to positively influence registries with better standardisation of approaches, individual registry entries are largely incomplete. Initiatives to ensure quality assurance of registries and trial data should be encouraged. Peer reviewers and editors should scrutinise clinical trial registration records to ensure consistency with WHO's core content requirements when considering trial-related publications.en_ZA
dc.description.versionPublishers' versionen_ZA
dc.format.extent12 p.
dc.identifier.citationMoja, L. P. et al. 2009. Compliance of clininal trial registries with the World Health Organization minimum data set : a survey. Trials, 10(1), 56, http://dx.doi.org/10.1186/1745-6215-10-56en_ZA
dc.identifier.issnhttp://dx.doi.org/10.1186/1745-6215-10-56
dc.identifier.urihttp://hdl.handle.net/10019.1/17397
dc.language.rfc3066en
dc.publisherBioMed Centralen_ZA
dc.rights.holderMoja et al.; licensee BioMed Central Ltd.en_ZA
dc.subjectClinical trial registriesen_ZA
dc.subjectWorld Health Organizationen_ZA
dc.titleCompliance of clinical trial registries with the World Health Organization minimum data set : a surveyen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
1745-6215-10-56.xml
Size:
161.3 KB
Format:
Extensible Markup Language
Description:
Loading...
Thumbnail Image
Name:
1745-6215-10-56.pdf
Size:
291.52 KB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
1745-6215-10-56-S1.DOC
Size:
41 KB
Format:
Microsoft Word
Description:
Loading...
Thumbnail Image
Name:
1745-6215-10-56-S2.DOC
Size:
42 KB
Format:
Microsoft Word
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: